Kirkland & Ellis advises Oakley Capital on the acquisition of a majority stake in vitroconnect. Oakley Capital is investing alongside vitroconnect founder and CEO Dirk Pasternack and his management team who will continue to run the business. The transaction is subject to regulatory approval and is expected to complete around the end of H1 2024. Based in Gütersloh, Germany, vitroconnect connects broadband providers with resellers through a proprietary, single interface software platform. The company works with most of Germany’s leading telco players, offering process automation, network operations, brokerage and white-label services through its Carrier Aggregation Platform (‘CAP’). Read Oakley Capital’s press release The Kirkland team advising Oakley Capital was led by transactional partners Greta-Josefin Harnisch and Ben Leyendecker and included transactional associates Tamara Zehentbauer, Philipp Keinath, Jenia Dimitrova and Maximilian Licht.